Enthesitis in Patients With Knee Osteoarthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03897829|
Recruitment Status : Completed
First Posted : April 1, 2019
Last Update Posted : June 11, 2019
|Condition or disease|
The current study will based on a cross sectional hospital-based survey, conducted among patients with knee osteoarthritis , Knee will assessed for the following items in both sides while Patient lying supine with the knee flexed 40 degrees:
- Superior pole of the patella - quadriceps tendon enthesis: ● Quadriceps tendon thickness >6.1 mm ● Suprapatellar bursitis ● Superior pole of patella erosion ● Superior pole of patella enthesophyte.
- Inferior pole of the patella - proximal patellar ligament enthesis: ● Patellar ligament thickness >4 mm ● Inferior pole of patella erosion ● Inferior pole of patella enthesophyte.
- Tibial tuberosity - distal patellar ligament enthesis ● Patellar ligament thickness >4 mm ● Infrapatellar bursitis ● Tibial tuberosity erosion ● Tibial tuberosity enthesophyte.
Knee functional status was assessed using Knee injury and Osteoarthritis Outcome Score (KOOS) scale for Pain, other Symptoms, Activities of Daily Living (ADL), Sport and Recreation Function (Sport/Rec) and knee-related Quality of Life (QOL). Low knee function was considered if the patient had score 50 or more in any KOOS scale parameter.
|Study Type :||Observational|
|Actual Enrollment :||200 participants|
|Official Title:||Prevalence of Knee Cap Enthesitis in Patients With Knee Osteoarthritis, Cross Sectional Ultrasonographic Study.|
|Actual Study Start Date :||March 29, 2019|
|Actual Primary Completion Date :||May 1, 2019|
|Actual Study Completion Date :||May 30, 2019|
- Prevalence of knee cap enthesitis in patients with knee osteoarthritis [ Time Frame: two months ]Detection of the prevalence
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03897829
|Al-Azhar Faculty of medicine, Rheumatology Department|
|Cairo, Egypt, 11311|
|Al-Azhar university hospitals|
|Cairo, Egypt, 11311|